HEICO: Wencor Acquisition Synergies and Analysis
In Practise Analysis
inpractise.com/articles/heico-wencor-synergies
Below is an excerpt from the article. Full access is provided with an upgrade.
On May 15th, HEICO announced it had agreed to purchase Wencor, its largest competitor and the second largest PMA producer globally, for $1.9bn cash and $150m in HEI stock. Since the announcement, we’ve spent ~10+ hours interviewing Former HEICO, Wencor, and Airline MRO executives to understand potential implications of the acquisition.
This analysis shares our learnings with a focus on the synergies between HEICO and Wencor’s PMA, MRO, and distribution businesses. We also explore one overlooked advantage of the acquisition: the ‘Alternate Bill of Materials’ (ABOM) strategy. This transaction significantly improves HEI’s positioning to save airline maintenance costs across its full offering. We share the synergies within each commercial segment, the advantages of HEI’s vertical integration, and the opportunity to scale the ABOM strategy.
Related Content
HEICO / Wencor: PMA & Alternative Bill of Materials (ABOM)
Former EVP at Wencor and Honeywell
Boeing, TransDigm, & a History of Aftermarket Distribution
Former Managing Director at Boeing, Supplier Services
HEICO, PMA History, and Pricing vs OEM
Former President at Wencor
HEICO PMA and MRO: Airline Customer Perspective
Former VP MRO, Delta Air Lines
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities.
© 2024 IP 1 Ltd. All rights reserved.